WALD
Waldencast plc NASDAQ Listed May 12, 2021$1.46
-1.35%
vs $1.48
Mkt Cap $166.5M
52w Low $0.76
30.1% of range
52w High $3.08
50d MA $1.39
200d MA $1.68
P/E (TTM)
-0.6x
EV/EBITDA
—
P/B
0.3x
Debt/Equity
0.3x
ROE
-49.7%
P/FCF
-10.3x
RSI (14)
31.90
ATR (14)
$0.13
Beta
-0.07
50d MA
$1.39
200d MA
$1.68
Avg Volume
808.4K
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
10 Bank Street · White Plains, NY 10606 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | AMC | -0.15 | -0.51 | -240.0% | 1.58 | +0.6% | -0.6% | -0.6% | -7.1% | -8.3% | -10.5% | — |
| Jan 6, 2026 | AMC | -0.07 | -0.09 | -20.0% | 1.56 | +0.6% | -3.8% | -2.0% | +0.7% | +10.1% | -0.6% | — |
| May 13, 2025 | AMC | -0.04 | -0.28 | -612.2% | 3.03 | +0.0% | -20.8% | -8.3% | -4.1% | +0.5% | +2.8% | — |
| Nov 20, 2024 | AMC | -0.05 | -0.11 | -120.0% | 3.41 | +8.5% | +0.9% | -3.5% | +0.6% | -1.2% | -0.3% | — |
| May 21, 2024 | AMC | 0.04 | -0.64 | -1701.8% | 4.91 | -4.3% | -11.4% | -6.4% | +2.7% | +0.0% | +1.0% | — |
| Jan 16, 2024 | AMC | -0.01 | -0.49 | -7245.9% | 8.70 | -3.0% | +3.6% | -8.8% | +2.6% | -3.9% | -1.6% | — |
| Jun 29, 2023 | AMC | — | -0.11 | — | 7.75 | -0.1% | -0.3% | -2.6% | -1.9% | -10.3% | +4.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 | Telsey Advisory Group | Maintains | Market Perform → Market Perform | — | $1.58 | $1.59 | +0.6% | -0.6% | -0.6% | -7.1% | -8.3% | -10.5% |
| Mar 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.58 | $1.59 | +0.6% | -0.6% | -0.6% | -7.1% | -8.3% | -10.5% |
| Nov 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.88 | $2.73 | -5.2% | -11.1% | +2.7% | -4.2% | -5.6% | -1.7% |
| Nov 25 | Telsey Advisory Group | Downgrade | Outperform → Market Perform | — | $2.88 | $2.73 | -5.2% | -11.1% | +2.7% | -4.2% | -5.6% | -1.7% |
| Aug 20 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $1.80 | $1.71 | -5.0% | -5.6% | -2.9% | +4.8% | +1.7% | -9.7% |
| Aug 13 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $1.88 | $1.90 | +1.1% | +2.1% | -4.2% | -6.0% | +4.0% | +0.0% |
| May 15 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.40 | $2.38 | -0.8% | -8.3% | -4.1% | +0.5% | +2.8% | -0.5% |
| May 15 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $2.40 | $2.38 | -0.8% | -8.3% | -4.1% | +0.5% | +2.8% | -0.5% |
| May 6 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $2.72 | $2.67 | -1.8% | -0.4% | +3.3% | -3.6% | +4.4% | +9.2% |
| Mar 20 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.20 | $3.16 | -1.2% | -2.2% | -0.6% | +1.3% | -3.2% | +2.3% |
| Mar 19 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.31 | $2.88 | -13.0% | -3.3% | -2.2% | -0.6% | +1.3% | -3.2% |
| Mar 19 | DA Davidson | Maintains | Buy → Buy | — | $3.31 | $2.88 | -13.0% | -3.3% | -2.2% | -0.6% | +1.3% | -3.2% |
| Mar 11 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.12 | $3.17 | +1.6% | -0.6% | +1.3% | -1.3% | +3.5% | -0.6% |
| Dec 4 | DA Davidson | Maintains | Buy → Buy | — | $3.25 | $3.32 | +2.2% | +0.0% | -1.2% | -1.9% | +4.4% | +6.4% |
| Nov 22 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.44 | $3.50 | +1.7% | -3.5% | +0.6% | -1.2% | -0.3% | +2.7% |
| Nov 22 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.44 | $3.50 | +1.7% | -3.5% | +0.6% | -1.2% | -0.3% | +2.7% |
| Nov 18 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.22 | $3.23 | +0.3% | +0.3% | +0.3% | +5.2% | +0.9% | -3.5% |
| Oct 9 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.44 | $3.44 | +0.0% | +0.0% | -3.5% | +0.0% | +0.0% | +4.2% |
| Sep 4 | DA Davidson | Maintains | Buy → Buy | — | $3.01 | $3.02 | +0.3% | +14.3% | +6.4% | -3.8% | +13.9% | +3.5% |
| Aug 29 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $3.06 | $3.15 | +2.9% | +0.0% | +4.6% | -5.9% | +14.3% | +6.4% |
| Aug 20 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $2.91 | $2.89 | -0.7% | -1.0% | +3.5% | +2.7% | +7.5% | -6.7% |
| May 28 | DA Davidson | Maintains | Buy → Buy | — | $4.18 | $4.14 | -1.0% | +0.0% | +1.0% | -0.9% | +1.9% | +5.4% |
| May 22 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $4.91 | $4.70 | -4.3% | -11.4% | -6.4% | +2.7% | +0.0% | +1.0% |
| May 21 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $4.35 | $4.35 | +0.0% | +12.9% | -11.4% | -6.4% | +2.7% | +0.0% |
| May 1 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $4.87 | $4.91 | +0.8% | +3.7% | +0.8% | -0.6% | -0.6% | -2.8% |
| Mar 22 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $7.30 | $7.19 | -1.5% | -11.9% | +0.5% | +1.2% | -2.1% | +1.6% |
| Feb 1 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $7.05 | $7.15 | +1.4% | -9.4% | +6.7% | -2.1% | +5.2% | -4.4% |
| Jan 17 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $8.70 | $8.44 | -3.0% | +3.6% | -8.8% | +2.6% | -3.9% | -1.6% |
| Jul 24 | Raymond James | Downgrade | Outperform → Market Perform | — | $6.49 | $6.41 | -1.2% | -3.2% | -9.7% | -0.9% | -2.1% | -0.9% |
| Nov 17 | DA Davidson | Maintains | Buy → Buy | — | $9.99 | $9.59 | -4.1% | -0.7% | +0.8% | -3.3% | +0.8% | +0.0% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Zeno Equity Partners Llp | 24,505,160 | $23M | — | Mar 2026 |
| 2 | Milestones Administradora De Recursos Ltda. | 2,425,677 | $2M | — | Mar 2026 |
| 3 | Stoic Point Capital Management Llc | 1,637,010 | $2M | New | Mar 2026 |
| 4 | Morgan Stanley | 289,136 | $544K | Added | Dec 2025 |
| 5 | Beartown Capital Management, Llc | 300,000 | $285K | — | Mar 2026 |
| 6 | Vanguard Portfolio Management Llc | 280,093 | $266K | New | Mar 2026 |
| 7 | Northern Trust Corp | 246,865 | $234K | Added | Mar 2026 |
| 8 | Eversource Wealth Advisors, Llc | 18,118 | $169K | Added | Mar 2026 |
| 9 | Bank Of New York Mellon Corp | 106,112 | $101K | Added | Mar 2026 |
| 10 | Ubs Group Ag | 82,950 | $79K | Reduced | Mar 2026 |
| 11 | Nuveen, Llc | 56,635 | $54K | — | Mar 2026 |
| 12 | Aqr Capital Management Llc | 49,219 | $47K | Added | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 42,676 | $40K | Added | Mar 2026 |
| 14 | Cibc Asset Management Inc | 24,642 | $23K | — | Mar 2026 |
| 15 | Jpmorgan Chase & Co | 20,437 | $19K | Reduced | Mar 2026 |
| 16 | Wells Fargo & Company/mn | 18,265 | $17K | New | Mar 2026 |
| 17 | Susquehanna International Group, Llp | 16,991 | $16K | New | Mar 2026 |
| 18 | Simplicity Wealth,llc | 16,975 | $16K | Reduced | Mar 2026 |
| 19 | Bnp Paribas Financial Markets | 15,567 | $15K | Added | Mar 2026 |
| 20 | Barclays Plc | 11,571 | $11K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 16
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | VANGUARD RUSSELL 2000 INDEX FUND | 210,297 | $355K | Feb 2026 |
| 2 | Nuveen Small Cap Blend Index Fund | 55,467 | $100K | Jan 2026 |
| 3 | VANGUARD RUSSELL 2000 VALUE INDEX FUND | 30,817 | $52K | Feb 2026 |
| 4 | Global X Russell 2000 ETF | 19,686 | $36K | Jan 2026 |
| 5 | Small Cap Index Fund | 30,777 | $29K | Mar 2026 |
| 6 | SIIT EXTENDED MARKET INDEX FUND | 7,000 | $12K | Feb 2026 |
| 7 | Avantis U.S. Small Cap Equity ETF | 2,787 | $5K | Feb 2026 |
| 8 | VANGUARD RUSSELL 3000 INDEX FUND | 2,485 | $4K | Feb 2026 |
| 9 | SmallCap Value Fund II | 2,028 | $4K | Jan 2026 |
| 10 | Destinations Small-Mid Cap Equity Fund | 671 | $1K | Feb 2026 |
| 11 | ULTRA SMALL CAP PROFUND | 541 | $979 | Jan 2026 |
| 12 | Penn Series Small Cap Index Fund | 1,000 | $950 | Mar 2026 |
| 13 | Knights of Columbus U.S. ALL CAP INDEX FUND | 222 | $402 | Jan 2026 |
| 14 | Russell 2000 Fund | 99 | $94 | Mar 2026 |
| 15 | SMALL-CAP PROFUND | 43 | $78 | Jan 2026 |
| 16 | Russell 2000 1.5x Strategy Fund | 59 | $56 | Mar 2026 |
Valuation
Market Cap
$166.5M
Enterprise Value
$270.4M
P/E (TTM)
-0.61x
Forward P/E
—
PEG Ratio
-0.00x
P/B
0.33x
P/S
0.31x
P/FCF
-10.25x
EV/EBITDA
—
Shares Out
114.1M
Financials (TTM)
Revenue
$545.9M
Net Income
-$272.2M
EBITDA
-$152.0M
Free Cash Flow
-$16.2M
Op Cash Flow
-$12.8M
EPS Basic
$-2.01
EPS Diluted
$-2.40
EPS Forward
$-0.61
Gross Margin
57.8%
Op Margin
-22.0%
Net Margin
-49.9%
Balance Sheet
Total Assets
$816.2M
Total Liab.
$316.1M
Total Equity
$500.1M
Cash
$31.9M
LT Debt
$135.8M
Book Value/Sh
$4.38
Debt/Equity
0.32x
Current Ratio
1.70
Quick Ratio
0.97
Returns & Growth
ROE
-49.7%
ROA
-30.8%
ROIC
-7.8%
Rev Growth YoY
-0.7%
EPS Growth YoY
-415.4%
Price Returns
2W
-24.5%
1M
+38.2%
3M
-27.2%
6M
-51.2%
12M
-54.3%
Technicals
52W High
$3.08
52W Low
$0.76
50d MA
$1.39
200d MA
$1.68
RSI (14)
31.90
ATR (14)
$0.13
Beta
-0.07
Avg Volume
808K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$2.50
High
$3.00
Low
$2.00
Median
$2.50
Data updated apr 24, 2026 11:30am
· Source: financialmodelingprep.com